Liver cancer treatment showdown: which combo causes less damage?
NCT ID NCT07277192
Summary
This completed study compared two different combination treatments for people with intermediate-to-advanced liver cancer. Researchers wanted to see which approach caused less liver damage while controlling the cancer. They followed 562 patients who received either HAIC or TACE procedures combined with immunotherapy and targeted drugs, tracking liver injury and survival outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATECELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
Conditions
Explore the condition pages connected to this study.